ProShares Ultra NASDAQ Biotechnology
20 hedge funds and large institutions have $15.6M invested in ProShares Ultra NASDAQ Biotechnology in 2014 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 8 increasing their positions, 0 reducing their positions, and 3 closing their positions.
Holders
20
Holders Change
+9
Holders Change %
+81.82%
% of All Funds
0.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
8
Reduced
–
Closed
3
Calls
$8.1M
Puts
$9.51M
Net Calls
-$1.41M
Net Calls Change
-$1.4M